Inhaled corticosteroid dose-reducing effect of omalizumab in patients with controlled, severe asthma according to usage of inhaled long-acting beta-agonists

被引：3

作者：

Chung, KF

Holgate, S

O'Brien, J

Fox, H

Thirlwell, J

机构：

[1] Natl Heart & Lung Inst, London, England

[2] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England

[3] City Pk Med Ctr, Cape Town, South Africa

[4] Novartis Pharmaceut Corp, Horsham, W Sussex, England

来源：

关键词：

D O I：

10.1016/S0091-6749(02)81861-9

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

726

引用

页码：S239 / S239

页数：1